Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 469 results

Search term: MF = 'C_{30}H_{35}ClN_{2}O_{3}'
12345
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
8111640
InChI=1/C30H34N2O3.ClH/c1-22-28-20-26(34)12-15-29(28)32(30(22)24-8-10-25(33)11-9-24)21-23-6-13-27(14-7-23)35-19-18-31-16-4-2-3-5-17-31;/h6-15,20,33-34H,2-5,16-19,21H2,1H3;1H
C30H35ClN2O3507.0635332400
55247

Charge
InChI=1/C30H35N2O3.ClH/c1-6-31(7-2)21-15-17-25-27(19-21)35-28-20-22(32(8-3)9-4)16-18-26(28)29(25)23-13-11-12-14-24(23)30(33)34-10-5;/h11-20H,6-10H2,1-5H3;1H/q+1;/p-1
C30H35ClN2O3507.0635242100
2139630

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C30H35ClN2O3/c1-6-33(7-2)24-14-10-21(11-15-24)28-27(30(35)36-18(3)4)19(5)32-25-16-22(17-26(34)29(25)28)20-8-12-23(31)13-9-20/h8-15,18,22,28,32H,6-7,16-17H2,1-5H3
C30H35ClN2O3507.0635231600
21835132

Double-bond stereo
InChI=1/C30H35ClN2O3/c1-29(2,3)20-30(4,5)24-11-13-25(14-12-24)36-19-28(35)33-32-18-23-17-21(10-15-27(23)34)16-22-8-6-7-9-26(22)31/h6-15,17-18,34H,16,19-20H2,1-5H3,(H,33,35)/b32-18+
C30H35ClN2O3507.063510800
2320473

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C30H34N2O3.ClH/c1-34-26-17-15-22(16-18-26)29-19-27-28(32(29)24-11-6-3-7-12-24)13-8-14-30(27)35-21-25(33)20-31-23-9-4-2-5-10-23;/h3,6-8,11-19,23,25,31,33H,2,4-5,9-10,20-21H2,1H3;1H
C30H35ClN2O3507.06358600
22736678

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C30H35ClN2O3/c1-3-28(24-9-5-4-6-10-24)30(34)33-18-16-32(17-19-33)21-29(25-12-14-26(31)15-13-25)36-22-23-8-7-11-27(20-23)35-2/h4-15,20,28-29H,3,16-19,21-22H2,1-2H3
C30H35ClN2O3507.06357600
7910437

Double-bond stereo
InChI=1/C30H35ClN2O3/c1-2-3-4-5-6-7-8-9-10-15-29(34)33-32-22-27-26-14-12-11-13-23(26)18-21-28(27)36-30(35)24-16-19-25(31)20-17-24/h11-14,16-22H,2-10,15H2,1H3,(H,33,34)/b32-22+
C30H35ClN2O3507.06355400
7937130

Double-bond stereo
InChI=1/C30H35ClN2O3/c1-2-3-4-5-6-7-8-9-10-19-29(34)33-32-22-26-24-16-12-11-15-23(24)20-21-28(26)36-30(35)25-17-13-14-18-27(25)31/h11-18,20-22H,2-10,19H2,1H3,(H,33,34)/b32-22+
C30H35ClN2O3507.06355400
17245925

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C30H35ClN2O3/c31-22-9-6-19(7-10-22)3-1-2-15-32-30-13-12-24(35)28-29(30)14-16-33(18-20-4-5-20)25(30)17-21-8-11-23(34)27(36-28)26(21)29/h6-11,20,25,28,32,34H,1-5,12-18H2/t25-,28+,29+,30-/m1/s1
C30H35ClN2O3507.06354400
17245927

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C30H35ClN2O3/c1-35-24-11-8-21-17-25-30(32-15-2-3-19-6-9-22(31)10-7-19)13-12-23(34)28-29(30,26(21)27(24)36-28)14-16-33(25)18-20-4-5-20/h6-11,20,25,28,32H,2-5,12-18H2,1H3/t25-,28+,29+,30-/m1/s1
C30H35ClN2O3507.06354400
77204203
InChI=1/C30H35ClN2O3/c1-22(2)20-33-12-13-35-14-15-36-29-11-8-26(30(34)32-19-23-6-9-28(31)10-7-23)18-27(29)17-24-4-3-5-25(16-24)21-33/h3-11,16,18,22H,12-15,17,19-21H2,1-2H3,(H,32,34)
C30H35ClN2O3507.06353300
12134346

Double-bond stereo
InChI=1/C30H35ClN2O3/c1-29(2,3)21-30(4,5)24-12-16-26(17-13-24)36-20-28(34)33-32-18-22-10-14-25(15-11-22)35-19-23-8-6-7-9-27(23)31/h6-18H,19-21H2,1-5H3,(H,33,34)/b32-18+
C30H35ClN2O3507.06353200
2561146

Double-bond stereo
InChI=1/C30H35ClN2O3/c1-2-3-4-5-6-7-8-9-10-19-29(34)33-32-22-26-24-16-12-11-15-23(24)20-21-28(26)36-30(35)25-17-13-14-18-27(25)31/h11-18,20-22H,2-10,19H2,1H3,(H,33,34)
C30H35ClN2O3507.06353200
3030265

Double-bond stereo
InChI=1/C30H35ClN2O3/c1-2-3-4-5-6-7-8-9-10-15-29(34)33-32-22-27-26-14-12-11-13-23(26)18-21-28(27)36-30(35)24-16-19-25(31)20-17-24/h11-14,16-22H,2-10,15H2,1H3,(H,33,34)
C30H35ClN2O3507.06353200
24694039

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C30H35ClN2O3/c1-32(2)21-26(20-22-10-12-24(31)13-11-22)33(25-14-16-30(17-15-25)35-18-19-36-30)29(34)28-9-5-7-23-6-3-4-8-27(23)28/h3-13,25-26H,14-21H2,1-2H3
C30H35ClN2O3507.06353300
28942415

Double-bond stereo

6 of 6 defined stereocentres - 6/6 defined
InChI=1/C30H35ClN2O3/c1-33-15-13-29-25-20-7-10-23(34)26(25)36-27(29)30(35-2)12-11-28(29,24(33)16-20)17-21(30)18-32-14-3-4-19-5-8-22(31)9-6-19/h3-10,21,24,27,32,34H,11-18H2,1-2H3/b4-3+/t21-,24-,27-,28-,29+,30+/m1/s1
C30H35ClN2O3507.06353300
59005873

Double-bond stereo

5 of 5 defined stereocentres - 5/5 defined
InChI=1/C30H34N2O3.ClH/c1-31(28(34)9-4-21-10-13-35-19-21)26-17-29-11-12-32(18-20-2-3-20)27-8-6-23(26)16-30(27,29)15-22-5-7-24(33)14-25(22)29;/h4-10,13-14,19-20,23,26-27,33H,2-3,11-12,15-18H2,1H3;1H/b9-4+;/t23-,26+,27+,29-,30-;/m1./s1
C30H35ClN2O3507.06353300
59006215

Double-bond stereo

5 of 5 defined stereocentres - 5/5 defined
InChI=1/C30H34N2O3.ClH/c1-31(28(34)9-4-21-10-13-35-19-21)26-17-29-11-12-32(18-20-2-3-20)27-8-6-23(26)16-30(27,29)15-22-5-7-24(33)14-25(22)29;/h4-10,13-14,19-20,23,26-27,33H,2-3,11-12,15-18H2,1H3;1H/b9-4+;/t23-,26-,27+,29-,30-;/m1./s1
C30H35ClN2O3507.06353300
68474345

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C30H35ClN2O3/c1-5-15-32-30(35)27(18-24-11-7-6-8-12-24)33(19-25-13-9-10-14-26(25)31)29(34)20-36-28-17-21(2)16-22(3)23(28)4/h6-14,16-17,27H,5,15,18-20H2,1-4H3,(H,32,35)
C30H35ClN2O3507.06352100
68474346

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C30H35ClN2O3/c1-4-18-32-30(35)27(19-23-12-6-5-7-13-23)33(20-24-14-8-10-16-26(24)31)29(34)21-36-28-17-11-9-15-25(28)22(2)3/h5-17,22,27H,4,18-21H2,1-3H3,(H,32,35)
C30H35ClN2O3507.06352100
12345

Advertisement